ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
AstraZeneca
AstraZeneca is looking for a scientist with mass spectrometry‑based proteomics expertise to develop and apply MS technologies for clinical biomarker studies in oncology. The role involves processing clinical samples, generating high‑quality PRM and DIA data, operating LC‑MS instruments, and collaborating with bioinformatics teams to translate proteomic insights into therapeutic and biomarker hypotheses.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
99% above the average for this role
Associate Scientist Discovery Proteomics
Amgen
Mass Spectrometry and Proteomics Specialist
University of Nebraska Medical Center
Mass Spectrometry Scientist (LC-MS/MS – Peptides/Proteomics)
Eurofins
Associate Scientist - Proteomics
University of Miami
Scientist / Senior Scientist in Mass Spectrometry-based Proteome Research
University of Helsinki
Scientist in Pharmacokinetics
Merck & Co., Inc.